Filing Details
- Accession Number:
- 0001209191-22-061217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-14 16:31:30
- Reporting Period:
- 2022-12-12
- Accepted Time:
- 2022-12-14 16:31:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1741830 | Kronos Bio Inc. | KRON | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826766 | Christopher Dinsmore | C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-12 | 9,138 | $1.81 | 162,936 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
Billionaire Hedge Funds
